Home › Bladder Cancer › California › Santa Barbara
Bladder Cancer clinical trials in Santa Barbara, CA
3 studies for Bladder Cancer are looking for participants at sites in and around Santa Barbara (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RecruitingPhase 3
- Samsun Clinic - Ridley-Tree Cancer Center, Santa Barbara
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RecruitingPhase 1/2
- UCLA Hematology/Oncology- Santa Barbara, Santa Barbara
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RecruitingPhase 2
- UCLA Montecito Primary & Specialty Care, Montecito · 4 mi away
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY35 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Dallas, TX27 studies
- Boston, MA26 studies
- Washington, DC26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Philadelphia, PA21 studies
- Seattle, WA21 studies
- Edison, NJ21 studies
Other studies in Santa Barbara
- Cancer (all types)7 studies
- Breast Cancer6 studies
- Non-Small Cell Lung Cancer5 studies
- Ovarian Cancer5 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
- Pulmonary Hypertension3 studies
- Endometrial Cancer3 studies
- Pulmonary Arterial Hypertension3 studies
- Metastatic Cancer3 studies
- Prostate Cancer3 studies
- Type 2 Diabetes3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.